Iterum Therapeutics Plc (ITRM) Misses Q3 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Paramount seeks $1.88B bond from state AGs to cover costs of WBD merger delay - CNBC
• Trump on North Korea's Kim Jong Un: he has responded to me